Full name
BG PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.90.E - Healthcare
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.90.Z - Non-specialized wholesale trade
47.19.Z - Retail trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.99.Z - Retail trade
63.11.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
86.90.C - Healthcare
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0 | -0,1 | -589,8 |
EBITDA | 0 | 0 | -0,1 | -575,9 |
Short time liabilities | 0,3 | 1,3 | 1,5 | 15,8 |
Equity capital | -0,1 | -0 | -0,1 | -266,2 |
Operating profit (EBIT) | 0 | 0 | -0,1 | -589,7 |
Assets | 0,2 | 1,3 | 1,4 | 8,3 |
Net profit (loss) | 0 | 0 | -0,1 | -641,3 |
Cash | 0,1 | 0,1 | 0,1 | -53,9 |
Net income from sale | 0,2 | 0,8 | 1,2 | 41,4 |
Liabilities and provisions for liabilities | 0,3 | 1,3 | 1,5 | 15,8 |
Working assets | 0,2 | 1,3 | 1,4 | 5,8 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -21,1 | -49,2 | 72,7 | 121,9 |
Equity capital to total assets | -26,8 | -3 | -10,1 | -7,1 |
Gross profit margin | 5,4 | 2,6 | -8,9 | -11,5 |
EBITDA Margin | 5,4 | 2,6 | -8,7 | -11,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 445 | 594 | 487 | -107 |
Current financial liquidity indicator | 0.7886062264442444 | 0.9709173440933228 | 0.8872502446174622 | -0,1 |
Net dept to EBITDA | 0.09417076408863068 | -0.5735918283462524 | -0.4846559762954712 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane